Dallas and Seattle – April 11, 2017 – Aprima Medical Software, a leading provider of innovative electronic health records (EHR), practice management (PM) and revenue cycle management (RCM) solutions for medical practices, today announced plans to integrate the ActX Genomic Decision Support platform within the Aprima EHR. The addition of the ActX platform provides Aprima clients with access to genomics in everyday patient care and delivers clinically actionable insights that facilitate personalized medication and screening choices based on a patient's unique genetic profile.

"We are very excited to partner with Aprima to make precision medicine a reality for their customers, personalizing and improving the quality of care," said Andrew Ury M.D., ActX CEO. "We are proud to help Aprima make genomics a practical part of everyday medical care by building genomic decision support into their normal physician workflow."

The integration of ActX real-time genomic decision support into the Aprima EHR means providers who use Aprima will get drug genomic interaction alerts as part of their normal prescription workflow. Using ActX within Aprima helps providers by informing them of possible issues regarding medication efficacy, adverse reactions or dosing. The combined solution gives providers critical patient information to help them personalize therapies and manage actionable hereditary risks. Having an integrated patient genomic profile empowers providers to take proactive steps to tailor care plans and minimize the potential negative health-related effects of actionable hereditary conditions. ActX's innovative solution makes genomics practical for Aprima clients, ushering in a new era of precision medicine. Patient data is frequently re-analyzed based on the latest evidence, and physicians are updated as necessary.
"Personalized medicine, including the incorporation of genetics into everyday care, is an exciting development for healthcare and holds great promise for improving patient health outcomes," said Michael Nissenbaum, Aprima CEO and president. "ActX is highly regarded in the industry and known for delivering comprehensive testing services and providing quality integration. We believe this is the ideal partner for helping us make this cutting-edge technology readily available to our customers."

The ActX Genomic Decision Support platform will be available through the Aprima EHR beginning in late summer 2017.

Health IT Homepage